Antimicrobial Resistance in developing Asian countries: burgeoning challenge to global health security demanding innovative approaches
Antimicrobial resistance (AMR) has been recognized by global leadership as the biggest - and the harshest challenge to the economic development of the humanity and the global health security. Factors responsible for burgeoning AMR are well known. Possible avenues for rapid containment of this scourg...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
University of New South Wales,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_53904d50387844a6b3d8ce97f9df5bc4 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Rajesh Bhatia |e author |
245 | 0 | 0 | |a Antimicrobial Resistance in developing Asian countries: burgeoning challenge to global health security demanding innovative approaches |
260 | |b University of New South Wales, |c 2019-05-01T00:00:00Z. | ||
500 | |a 2652-0036 | ||
500 | |a 10.31646/gbio.4 | ||
520 | |a Antimicrobial resistance (AMR) has been recognized by global leadership as the biggest - and the harshest challenge to the economic development of the humanity and the global health security. Factors responsible for burgeoning AMR are well known. Possible avenues for rapid containment of this scourge have also been articulated. Huge resources -both financial and technical are needed by the developing countries. In the absence of these, innovative cost-effective approaches are needed. Universal health coverage, and One Health approach that brings together human health, animal health and environmental impact to benefit health should be considered by resource-limited countries to implement in their countries with appropriate modifications that provide them with the best outcomes for their populations by preserving efficacy of currently available and affordable antimicrobial agents against infectious diseases. | ||
546 | |a EN | ||
690 | |a antimicrobial resistance, universal health coverage, One Health, Asian countries | ||
690 | |a Infectious and parasitic diseases | ||
690 | |a RC109-216 | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Global Biosecurity, Vol 1, Iss 2 (2019) | |
787 | 0 | |n https://jglobalbiosecurity.com/articles/4 | |
787 | 0 | |n https://doaj.org/toc/2652-0036 | |
856 | 4 | 1 | |u https://doaj.org/article/53904d50387844a6b3d8ce97f9df5bc4 |z Connect to this object online. |